20:25:50 EDT Sun 28 Apr 2024
Enter Symbol
or Name
USA
CA



C:BUX - BioMark Diagnostics Inc. - http://www.biomarkdiagnostics.com
Sym-XBid - AskLastChg%ChVol$Vol#TrOpen-Hi-LoYear Hi-LoLast TrNewsDelay
BUX - C  1.00.295·0.3011.50.30-0.005-1.613.0450.30  0.305  0.300.35  0.1713:27:53Apr 1815 min RT 2¢
CSE - C1.00.295·0.3011.50.30-0.005-1.613.0440.30  0.305  0.300.35  0.1713:27:5315 min
CXD - D 0.3050.0011    Sep 2215 min

Recent Trades - All 5 today
Time ETExPriceChangeVolumeBuyerSellerMarkers
13:27:53C0.30-0.0051,00036 Latimer33 CanaccordK
10:41:58C0.305 6,50036 Latimer59 PIK
10:41:40C0.30-0.0054,50079 CIBC59 PIK
10:41:40C0.30-0.0051,00036 Latimer59 PIK
10:34:21D0.320.015180 National Bank80 National BankE
        
        
        
        
        

Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS

Recent Bulletins
Date ETSymbolPriceTypeHeadline
2024-04-18 14:00C:BUX0.29News ReleaseBiomark Diagnostics to extend warrants by two years
2024-04-09 13:58C:BUX0.30News ReleaseBiomark to receive $290,000 funding for glioblastoma
2024-02-29 17:26C:BUX0.30SEDAR Interim Financial StatementsSEDAR Interim Financial Statements
2024-02-29 17:26C:BUX0.30SEDAR Interim MD & ASEDAR Interim MD & A
2024-02-28 13:41C:BUX0.30News ReleaseBiomark, Rubix sign cancer screening partnership
2024-02-26 15:50C:BUX0.30News ReleaseBiomark Diagnostics appoints Peterson to advisory group
2023-12-29 11:24C:BUX0.25News ReleaseBiomark closes $1.9-million private placement
2023-12-04 12:15C:BUX0.28News ReleaseBiomark receives Canadian legacy assay patent
2023-11-28 14:14C:BUX0.28News ReleaseBiomark omits Q2 net P&L in NR, talks revenue
2023-11-28 08:38C:BUX0.28SEDAR Interim MD & ASEDAR Interim MD & A
2023-11-28 08:35C:BUX0.28SEDAR Interim Financial StatementsSEDAR Interim Financial Statements
2023-11-14 14:37C:BUX0.28News ReleaseBiomark appoints Ford to advisory team
2023-11-07 13:33C:BUX0.28News ReleaseBiomark unit receives $231,000 financing from Quebec
2023-08-30 13:07C:BUX0.28News ReleaseBiomark appoints Cosgriff to advisory group
2023-08-28 08:34C:BUX0.24SEDAR Interim Financial StatementsSEDAR Interim Financial Statements
2023-08-28 08:32C:BUX0.24SEDAR Interim MD & ASEDAR Interim MD & A
2023-08-08 11:47C:BUX0.205News ReleaseBiomark Diagnostics receives Japanese biomarker patent
2023-07-31 17:52C:BUX0.23SEDAR Audited Annual Financial StatementsSEDAR Audited Annual Financial Statements
2023-07-25 09:44C:BUX0.235News ReleaseBiomark Diagnostics does not say why stock is down
2023-05-31 10:43C:BUX0.30News ReleaseBiomark receives U.S. patent for lung cancer assay